Evidence map›Paper›PMID 34353453›Full record

ReviewClinics in chest medicine2021

Pulmonary Considerations for Pregnant Women.

Nicholas Nassikas, Isabelle Malhamé, Margaret Miller, Ghada Bourjeily

Open access · greenAbstract readReview
In one paragraph

Review in Clinics in chest medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Assessment of target organ damage in hypertensive pregnancy.European journal of preventive cardiology · 2024
    Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Nicholas NassikasDepartment of Medicine, Pulmonary and Critical Care Medicine Fellowship, Lifespan Hospitals, Alpert Medical School of Brown University, 593 Eddy Street, Providence, RI 02903, USA.
Isabelle MalhaméDepartment of Medicine, Obstetric Medicine Division, McGill University Health Center and Research Institute of the McGill University Health Center, 1001 Decarie Boulevard, D05.5839.3, Montreal, Quebec H4A 3J1, Canada.
Margaret MillerDepartment of Medicine, Division of Obstetric Medicine, Lifespan Hospitals, Alpert Medical School of Brown University, 146 West River Street, Suite 11C, Providence, RI, USA.
Ghada BourjeilyDepartment of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Lifespan Hospitals, Warren Alpert Medical School of Brown University, 146 West River Street, Suite 1F, Providence, RI 02904, USA; Department of Medicine, Division of Obstetric Medicine, Lifespan Hospitals, Warren Alpert Medical School of Brown University, 146 West River Street, Suite 1F, Providence, RI 02904, USA. Electronic address: Ghada_Bourjeily@brown.edu.
Brown University · USLifespan · USMcGill University Health Centre · CA

Funding

Placental role in mediating adverse outcomes in obstructive sleep apneaR01HD078515 · NICHD · MIRIAM HOSPITAL · PI BOURJEILY, GHADA · 2014 to 2018
$2.7M
Predictors of de novo development of obstructive sleep apnea in pregnancyR01HL130702 · NHLBI · MIRIAM HOSPITAL · PI BOURJEILY, GHADA · 2016 to 2020
$2.6M
NHLBI NIH HHS R01 HL130702NICHD NIH HHS R01 HD078515
6 · The paper itself

Abstract

Maternal mortality is increasing in the United States; many maternal deaths are linked to substandard care and withholding diagnostic tests or therapeutic options for fear of harm. Respiratory conditions are common in this population; however, caring for pregnant women with respiratory disease is complicated by physiologic changes. Safety of diagnostic tests as well as therapeutic interventions, changes in pharmacodynamics, and potential teratogenicity complicate the care of this population further. Appropriate care of pregnant women with respiratory conditions requires a good understanding of these nuances in the management, to provide appropriate care and improve the health and well-being of pregnant women.

Indexed as

LungPregnant PeopleFemaleHumansPregnancyUnited StatesImagingPharmacotherapyPreconception counselingPregnancyPulmonary disease

Identifiers

PMID34353453
PMCPMC9636841
OpenAlexW3188782170

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.